• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠中激肽释放酶-激肽系统对血管紧张素转换酶抑制剂的反应。

Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.

作者信息

Yasujima M, Abe K, Tanno M, Omata K, Yoshinaga K

出版信息

Jpn Circ J. 1984 Feb;48(2):173-9. doi: 10.1253/jcj.48.173.

DOI:10.1253/jcj.48.173
PMID:6321815
Abstract

Three structurally different drugs, MK421, SA446 and captopril, are angiotensin converting enzyme inhibitors. They induced a significantly greater fall in systolic blood pressure in sodium depleted rats than in sodium repleted ones. The combined administration of vasopressin or norepinephrine with MK421 eliminated the hypertensive effect of vasopressin or norepinephrine. Urinary kallikrein and kinin excretion were increased by MK421, SA446 or captopril in the sodium depleted rats whereas any significant changes in them were not observed in the sodium repleted rats. The combined administration of norepinephrine with MK421 induced further increases in urinary kallikrein and kinin excretion when compared to rats infused with norepinephrine alone, whereas the combined administration of vasopressin with MK421 did not induce any changes in them when compared to rats infused with vasopressin alone. Chronic infusion of captopril for up to 6 days in the rats induced a reduction of the vascular response to exogenous bradykinin; the blood pressure fall was less than that of the controls by 17% on Day 2 and by 18% on Day 6. These results indicate that the hypotensive response to angiotensin converting enzyme inhibitors was in part associated with the enhanced renal and vascular smooth muscle kallikrein-kinin system.

摘要

三种结构不同的药物,MK421、SA446和卡托普利,均为血管紧张素转换酶抑制剂。与钠充足的大鼠相比,它们使钠缺乏的大鼠收缩压下降幅度明显更大。血管加压素或去甲肾上腺素与MK421联合给药可消除血管加压素或去甲肾上腺素的升压作用。MK421、SA446或卡托普利可使钠缺乏大鼠的尿激肽释放酶和激肽排泄增加,而在钠充足的大鼠中未观察到它们有任何显著变化。与单独输注去甲肾上腺素的大鼠相比,去甲肾上腺素与MK421联合给药可使尿激肽释放酶和激肽排泄进一步增加,而与单独输注血管加压素的大鼠相比,血管加压素与MK421联合给药对它们未产生任何影响。在大鼠中持续输注卡托普利长达6天可导致对外源性缓激肽的血管反应降低;血压下降幅度在第2天比对照组少17%,在第6天比对照组少18%。这些结果表明,对血管紧张素转换酶抑制剂的降压反应部分与肾和血管平滑肌激肽释放酶-激肽系统的增强有关。

相似文献

1
Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.大鼠中激肽释放酶-激肽系统对血管紧张素转换酶抑制剂的反应。
Jpn Circ J. 1984 Feb;48(2):173-9. doi: 10.1253/jcj.48.173.
2
Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.肾激肽释放酶-激肽系统以及血管紧张素转换酶抑制剂MK 421、SA 446和卡托普利对大鼠的降压作用。
Clin Exp Hypertens A. 1984;6(6):1207-25. doi: 10.3109/10641968409039592.
3
Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.血管紧张素转换酶抑制剂MK 421、SA 446和卡托普利对清醒正常血压大鼠肾前列腺素E和激肽的影响。
Clin Exp Hypertens A. 1987;9(2-3):401-4. doi: 10.3109/10641968709164205.
4
Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.MK-421对大鼠的降压作用。肾激肽释放酶-激肽系统的作用。
Hypertension. 1984 Mar-Apr;6(2 Pt 1):229-35.
5
Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Jpn Heart J. 1983 Nov;24(6):975-83. doi: 10.1536/ihj.24.975.
6
Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.三种结构不同的血管紧张素转换酶抑制剂(卡托普利、SA - 446和MK - 421)对血压、肾素 - 血管紧张素系统和激肽释放酶 - 激肽系统急性作用的比较。
Nihon Jinzo Gakkai Shi. 1985 Mar;27(3):337-42.
7
Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.卡托普利和依那普利对缺钠犬钠排泄及血压的影响。
Fed Proc. 1984 Apr;43(5):1336-41.
8
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Eur J Pharmacol. 1982 Mar 26;78(4):411-20. doi: 10.1016/0014-2999(82)90483-6.
9
A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Clin Exp Pharmacol Physiol. 1983 Mar-Apr;10(2):131-45. doi: 10.1111/j.1440-1681.1983.tb00179.x.
10
In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
Am J Cardiol. 1982 Apr 21;49(6):1502-4. doi: 10.1016/0002-9149(82)90368-x.

引用本文的文献

1
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.依那普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的综述。
Drugs. 1986 Mar;31(3):198-248. doi: 10.2165/00003495-198631030-00002.